HOG vs REGN · P/E 8.5, rev $5.19B vs P/E 14, rev $14.34B
Harley-Davidson Inc (HOG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Harley-Davidson Inc (HOG) is a recreational vehicles company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported HOG revenue for 2024-12-31 was $5.19B. Net income was $445.2M. Revenue was down 11.1% from 2023-12-31 to 2024-12-31. HOG currently screens at market cap $2.87B and trailing P/E 8.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
HOG currently screens at market cap $2.87B and trailing P/E 8.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the HOG and REGN stock pages for the full models.
Not investment advice.